Crispr Therapeutics Ag (CRSP)

$55.67 0.16 (0.28%)

16:00 EST CRSP Stock Quote Delayed 30 Minutes

3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later

By Ian Bezek, InvestorPlace Contributor Feb 2, 2023

CRISPR stocks are heating back up after a difficult 2022. These three names should be at the top of your watchlist.

7 CRISPR Stocks With the Best Long-Term Potential

3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later

3 Gene Editing Stocks With the Best Long-Term Potential

Volume:

Previous Close -

Market Cap 4.36B

PE Ratio -6.40

EPS -8.7

Volume (Avg. Vol.) 1.32M

Day's Range $53.50 - $57.22

52-Week Range $38.94 - $86.95

Dividend & Yield N/A (N/A)

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

From InvestorPlace
From the Web

7 Biotech Stocks That Will Make You Rich in 10 Years

By Josh Enomoto, InvestorPlace Contributor Jan 18, 2023

Although the health innovation space presents risks, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.

3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years

By Ian Cooper, InvestorPlace Contributor Jan 18, 2023

CRISPR could be revolutionary, leading us to put together this list of CRISPR stocks that will make you rich in ten years.

7 Stocks to Add to Your 10x Watchlist

By Chris Markoch, InvestorPlace Contributor Dec 16, 2022

It’s always a good time to look for stocks with exceptional growth potential. Here are seven 10x stocks for your watchlist

The Top 5 Stocks Cathie Wood Bought and Sold This Week

By Eddie Pan, InvestorPlace Assistant News Writer Oct 21, 2022

Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.

Why Is Crispr Therapeutics (CRSP) Stock Up Today?

By William White, InvestorPlace Writer Sep 27, 2022

Crispr Therapeutics (CRSP) stock is gaining on Tuesday after the FDA granted exagamglogene autotemcel (exa-cel) a rolling review.

The 7 Best Biotech Stocks to Buy

By Dana Blankenhorn, InvestorPlace Contributor Sep 20, 2022

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

7 Cathie Wood Stocks to Buy on the Dip

By Alex Sirois Aug 22, 2022

Cathie Wood stocks lost some of their shine in the tech wreck. But the second half of 2022 looks much brighter for these picks.

5 Cathie Wood Stocks Signaling “The Bear Market Is Over”

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Aug 22, 2022

These top Cathie Wood stocks are signalling that the bear market is over. For savvy investors, that presents a chance to profit.

Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today?

By Shrey Dua, InvestorPlace Assistant News Writer Aug 3, 2022

Gene editing stocks are a bright spot on the market today after Alnylam announced the success of one of its RNAi therapies, Patisiran.

7 No-Brainer Biotech Stocks to Add to Your Buy List

By Josh Enomoto, InvestorPlace Contributor Jun 9, 2022

With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.

5 Cathie Wood Stocks to Buy Now

By Tezcan Gecgil, InvestorPlace Contributor May 16, 2022

ARK Invest funds led by Cathie Wood seek long-term capital growth and focus mainly on disruptive innovation. Here's a look a five related stocks to consider.

3 Cathie Wood Stocks to Count on in Q2

By Muslim Farooque, InvestorPlace Contributor Apr 26, 2022

These Cathie Wood Stocks have their risks but offer a massive upside potential ahead

7 Potential Biotech Stocks Buyout Targets in 2022

By Shanthi Rexaline Apr 21, 2022

Big biopharma companies usually rely on M&A to get immediate access to a new class of drug or technology, fill in the gap in their pipeline and compensate for revenue loss from patent expiration of blockbuster products.

3 Best Stocks to Trade Right Now

By Chris Tyler, InvestorPlace Contributor Mar 24, 2022

Get past the persistently bearish headlines, and you'll find stocks to trade long in emerging bull markets that could be lucrative.

3 Ark Invest Most-Shorted Stocks to Buy

By Chris Tyler, InvestorPlace Contributor Mar 11, 2022

These most-shorted stocks have investors seeing red, but there is a silver lining that's playing out on the price chart for today's buyers.

3 Cathie Wood Stocks to Buy

By Chris Tyler, InvestorPlace Contributor Mar 9, 2022

Don't buy Cathie Wood stocks because the market was singing on Wednesday, purchase them because of a much bigger and bullish picture.

Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?

By Tezcan Gecgil, InvestorPlace Contributor Feb 23, 2022

Savvy investors can generate lucrative returns by investing in companies that look like prime takeover targets. This article speculates on a number of takeover targets of 2022.

7 Stock Bargains Worth a Look After the Most Recent Pullback

By Chris Lau, InvestorPlace Contributor Dec 27, 2021

Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors.

10 Bargain Stocks to Buy After Falling 30% in 2021

By Will Ashworth, InvestorPlace Contributor Dec 20, 2021

If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill.

CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments

By David Moadel, InvestorPlace Contributor Dec 9, 2021

Don't let the downtrend in CRSP stock fool you; the company is still making headway in advancing potentially life-changing therapeutics.

Crispr Therapeutics Ag (CRSP)

3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later

7 CRISPR Stocks With the Best Long-Term Potential

3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later

3 Gene Editing Stocks With the Best Long-Term Potential

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Crispr Therapeutics Ag (CRSP)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

Subscriber Sign in